We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+11.7%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$334B
AUM Growth
+$44B
Cap. Flow
+$10.5B
Cap. Flow %
3.13%
Top 10 Hldgs %
13.87%
Holding
10,649
New
1,223
Increased
4,779
Reduced
2,819
Closed
1,395

Sector Composition

Rank Sector Weight
1 Technology 13.13%
2 Financials 7.1%
3 Healthcare 6%
4 Consumer Discretionary 5.02%
5 Industrials 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCG icon
8801
Oriental Culture Holding
OCG
$3.12M
0
NXU
8802
DELISTED
Nxu, Inc. Class A Common Stock
NXU
$177 ﹤0.01%
4
CPSH icon
8803
CPS Technologies
CPSH
$75.5M
$176 ﹤0.01%
+75
New +$186
FGNX
8804
FG Nexus Inc
FGNX
$41.6M
$176 ﹤0.01%
+1
New +$171
SATL icon
8805
Satellogic
SATL
$531M
$175 ﹤0.01%
+100
New +$123
RDI icon
8806
Reading International Class A
RDI
$33.2M
$174 ﹤0.01%
91
-1,817
-95% -$3.47K
ATXI
8807
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$174 ﹤0.01%
+14
New +$328
SRZNW icon
8808
Surrozen Inc Warrant
SRZNW
$173 ﹤0.01%
+9,100
New +$186
DSMC icon
8809
Distillate Small/Mid Cash Flow ETF
DSMC
$137M
$172 ﹤0.01%
+5
New +$155
MTAL.WS
8810
DELISTED
Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share
MTAL.WS
$171 ﹤0.01%
100
CLVRW
8811
DELISTED
Clever Leaves Holdings Inc. Warrant
CLVRW
$171 ﹤0.01%
9,500
+9,384
+8,090% +$142
RMTI icon
8812
Rockwell Medical
RMTI
$28.4M
$170 ﹤0.01%
9
-376
-98% -$7.06K
ADVWW
8813
DELISTED
Advantage Solutions Warrant
ADVWW
$169 ﹤0.01%
+1,858
New +$259
PNBK icon
8814
Patriot National Bancorp
PNBK
$134M
$165 ﹤0.01%
43
SPEC
8815
DELISTED
Spectaire Holdings, Inc. Common Stock
SPEC
$165 ﹤0.01%
100
+97
+3,233% +$376
BRTX icon
8816
BioRestorative Therapies
BRTX
$5.22M
$164 ﹤0.01%
94
+93
+9,300% +$177
FRSX
8817
Foresight Autonomous Holdings
FRSX
$3.9M
$162 ﹤0.01%
7
CDIOW icon
8818
Cardio Diagnostics Holdings Inc Warrant
CDIOW
$730K
$160 ﹤0.01%
918
+771
+524% +$77
XXII
8819
22nd Century Group
XXII
$1.38M
0
TNON icon
8820
Tenon Medical
TNON
$3.44M
$158 ﹤0.01%
+13
New +$182
ZAPP
8821
DELISTED
Zapp Electric Vehicles
ZAPP
$157 ﹤0.01%
30
+24
+400% +$153
ATMVR
8822
DELISTED
AlphaVest Acquisition Corp Right
ATMVR
$156 ﹤0.01%
+1,302
New +$185
LABP
8823
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$154 ﹤0.01%
42
+5
+14% +$20
UNCY icon
8824
Unicycive Therapeutics
UNCY
$137M
$153 ﹤0.01%
18
-54
-75% -$353
RDHL
8825
Redhill Biopharma
RDHL
$3.95M
$152 ﹤0.01%
4
+1
+33% +$20

Similar funds

UBS Group's Q4 2023 Portfolio in Review

As of Q4 2023, UBS Group held 10,649 positions worth $334B, up 15% from $290B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group deployed $10.5B of net new capital in Q4 2023, opening 1,223 new positions and adding to 4,779 existing holdings. Its largest new stake was Veralto: 498,566 shares worth $41M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $503M trimmed.

  • UBS Group's largest Q4 2023 buy was Veralto: 498,566 shares worth $41M.
  • UBS Group added most to UBS Group in Q4 2023, an estimated $591M increase.
  • UBS Group's biggest Q4 2023 reduction was Invesco QQQ Trust, cutting an estimated $503M.
  • UBS Group fully exited Activision Blizzard in Q4 2023, selling an estimated $370M.
  • UBS Group's ten largest holdings make up 14% of its $334B portfolio in Q4 2023.
  • UBS Group opened 1,223 new positions and closed 1,395 in Q4 2023.
  • UBS Group's portfolio value rose 15% quarter-over-quarter to $334B.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.